Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Health Catalyst
HCAT
$159M
| $107K | ﹤0.01% |
16,761
+5,500
| +49% | +$35.3K |
|
4002
Northeast Bank
NBN
$1.04B
| $107K | ﹤0.01% |
1,755
+301
| +21% | +$16.6K |
|
4003
Orthofix Medical
OFIX
$486M
| $107K | ﹤0.01% |
8,042
-791
| -9% | -$10.8K |
|
4004
Atomera
ATOM
$177M
| $106K | ﹤0.01% |
27,937
+23,998
| +609% | +$113K |
|
4005
Tiptree Inc
TIPT
$694M
| $106K | ﹤0.01% |
6,446
+1,474
| +30% | +$24.6K |
|
4006
OrthoPediatrics
KIDS
$515M
| $106K | ﹤0.01% |
3,694
+1,020
| +38% | +$31.3K |
|
4007
Xometry
XMTR
$4.58B
| $106K | ﹤0.01% |
9,163
+2,883
| +46% | +$45.3K |
|
4008
SGHC Ltd
SGHC
$7.62B
| $105K | ﹤0.01% |
32,607
+10,081
| +45% | +$34K |
|
4009
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$140M
| $105K | ﹤0.01% |
2,221
+2,147
| +2,901% | +$102K |
|
|
UBFO
4010
DELISTED
United Security Bancshares
UBFO
| $105K | ﹤0.01% |
14,521
-4,972
| -26% | -$36.2K |
|
4011
Carriage Services
CSV
$642M
| $105K | ﹤0.01% |
3,909
+782
| +25% | +$20.5K |
|
4012
MacroGenics
MGNX
$236M
| $105K | ﹤0.01% |
24,635
-280,441
| -92% | -$2.73M |
|
4013
Tortoise North American Pipeline ETF
TPYP
$874M
| $105K | ﹤0.01% |
3,626
| – | – |
|
|
SHYF
4014
DELISTED
The Shyft Group
SHYF
| $104K | ﹤0.01% |
8,802
+2,385
| +37% | +$28.7K |
|
4015
Banco de Chile
BCH
$20.6B
| $104K | ﹤0.01% |
4,612
| – | – |
|
4016
Sierra Bancorp
BSRR
$537M
| $104K | ﹤0.01% |
4,654
+1,774
| +62% | +$36.3K |
|
4017
Peoples Financial Services
PFIS
$718M
| $104K | ﹤0.01% |
2,283
+831
| +57% | +$32.6K |
|
4018
Bar Harbor Bankshares
BHB
$669M
| $104K | ﹤0.01% |
3,865
+710
| +23% | +$18.2K |
|
|
OLP
4019
One Liberty Properties
OLP
$548M
| $104K | ﹤0.01% |
4,424
+681
| +18% | +$15.8K |
|
4020
Digimarc Corp
DMRC
$145M
| $103K | ﹤0.01% |
3,334
+962
| +41% | +$24.5K |
|
4021
Perspective Therapeutics
CATX
$318M
| $103K | ﹤0.01% |
10,305
-93,229
| -90% | -$1.35M |
|
4022
Schwab Emerging Markets Equity ETF
SCHE
$12.2B
| $103K | ﹤0.01% |
3,868
+1,387
| +56% | +$36.1K |
|
|
OLO
4023
DELISTED
Olo Inc
OLO
| $102K | ﹤0.01% |
23,164
+5,099
| +28% | +$24.1K |
|
4024
Xeris Biopharma Holdings
XERS
$1.45B
| $102K | ﹤0.01% |
45,345
+3,583
| +9% | +$7.22K |
|
|
HLVX
4025
DELISTED
HilleVax
HLVX
| $102K | ﹤0.01% |
7,033
+2,255
| +47% | +$31K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.